Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Weder

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Expert Opinion on Pharmacotherapy|March 11, 2005
The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapiesAlan B Weder
Current Hypertension Reports|March 28, 2008
One size fits all?Alan B Weder
Hypertension (Dallas, Tex. : 1979)|January 1, 1991
Membrane sodium transport and salt sensitivity of blood pressureA B Weder
Current Hypertension Reports|September 12, 2000
Selecting the right drug for initial antihypertensive therapyA B Weder
Current Hypertension Reports|January 18, 2003
Best bang for the buck?Alan B Weder
American Journal of Hypertension|November 1, 1991
Cation transport markers as predictors of hypertensionA B Weder
Postgraduate Medicine|April 1, 2009
ACCOMPLISH trial findings: combination benazepril-amlodipine or hydrochlorothiazide is effective for treating hypertension. CommentaryAlan B Weder
Journal of Clinical Hypertension (Greenwich, Conn.)|March 8, 2007
Genetics and hypertensionAlan B Weder
Current Hypertension Reports|February 20, 2004
Clinical trials report. Food fight: diet and genomicsAlan B Weder
American Journal of Hypertension|November 1, 1990
Renal protective effects of angiotensin converting enzyme inhibitorsA B Weder
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Expert Opinion on Pharmacotherapy|March 11, 2005
The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapiesAlan B Weder
Current Hypertension Reports|March 28, 2008
One size fits all?Alan B Weder
Hypertension (Dallas, Tex. : 1979)|January 1, 1991
Membrane sodium transport and salt sensitivity of blood pressureA B Weder
Current Hypertension Reports|September 12, 2000
Selecting the right drug for initial antihypertensive therapyA B Weder
Current Hypertension Reports|January 18, 2003
Best bang for the buck?Alan B Weder
American Journal of Hypertension|November 1, 1991
Cation transport markers as predictors of hypertensionA B Weder
Postgraduate Medicine|April 1, 2009
ACCOMPLISH trial findings: combination benazepril-amlodipine or hydrochlorothiazide is effective for treating hypertension. CommentaryAlan B Weder
Journal of Clinical Hypertension (Greenwich, Conn.)|March 8, 2007
Genetics and hypertensionAlan B Weder
Current Hypertension Reports|February 20, 2004
Clinical trials report. Food fight: diet and genomicsAlan B Weder
American Journal of Hypertension|November 1, 1990
Renal protective effects of angiotensin converting enzyme inhibitorsA B Weder
Pageof 17